Status:
UNKNOWN
Development and Evaluation of the Self-management Module in Patients With Multiple Sclerosis
Lead Sponsor:
Hacettepe University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Compared with other chronic disease states, MS patients feel more uncertainty and less control over illness and non-illness aspects of life, and as a result, they have poor self-management abilities. ...
Detailed Description
Multiple Sclerosis (MS) is a chronic, progressive central nervous system disease that cannot be cured in the light of current information. Disability, weakness, tremors, balance and movement problems,...
Eligibility Criteria
Inclusion
- over 18 years old,
- Diagnosed with MS and using medication for at least 45 days,
- Approved by the physician to participate in the study,
- Giving written consent,
- Patients who have been in a stable disease period (attack free period) for at least 30 days
Exclusion
- Has a disability that prevents communication,
- Involved in another clinical and/or drug trial,
- Patients who are pregnant / planning pregnancy during the study period
Key Trial Info
Start Date :
September 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05209113
Start Date
September 15 2020
End Date
September 15 2022
Last Update
January 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Sihhiye, Turkey (Türkiye), 06100